|3 min read
When Routine Lab Testing Triggers a False Arsenic Results
Two studies highlight potential pitfalls in routine arsenic testing and their implications for clinical interpretation
A LabX Media Group Partner Site
Emerging Diagnostic Modalities & Innovation
|3 min read
RNA: The Overlooked Diagnostic Powerhouse
As genomic testing expands, RNA sequencing can help resolve variants and disease mechanisms missed by DNA sequencing alone
A LabX Media Group Partner Site
Reliable business intelligence for clinical laboratories, pathology groups, & laboratory diagnostics since 1995.Start a 14-day Free Trial
Industry Policy & Workforce
Event Date:
What's Ahead for Laboratory Reimbursement: PAMA, Payer Scrutiny, and Compliance Risk in 2027
Join Dark Daily and TELCOR to learn how laboratories can prepare for 2027 reimbursement risks, strengthen audit readiness, and reduce avoidable revenue leakage.Sponsored by
A LabX Media Group Partner Site
News, analysis, trends, and management innovations for clinical laboratories and pathology groups.Read Now
Instruments, Equipment & Technology
|2 min read
Guardant Health Ordered to Pay $245 Million in DNA-Sequencing Patent Case
Ongoing royalties involving 11 Guardant cancer tests, raising the question of whether lab customers will eventually bear the brunt
A LabX Media Group Partner Site
Stay on top of legal and compliance developments affecting diagnostic labs.Start a Free Trial
Lab Operations & Management
Updated |4 min read
Beyond the Rapid Test: Automated Chemiluminescent Immunoassay Detection of Legionella and Streptococcus pneumoniae
As pneumonia diagnostics evolve, the focus is shifting toward faster, more accurate, and actionable testing
Laboratory Science & Testing
|2 min read
In a Regulatory Milestone, FDA Authorizes Vitestro’s Aletta
Technology could help clinical laboratories address phlebotomist shortages by allowing one trained professional to oversee three robotic blood-draw devices simultaneously
Quality Standards & Compliance
|2 min read
Study Finds Major Performance Differences Among p-Tau217 Blood Tests
A multicenter study comparing nine plasma p-tau217 assays found substantial differences in diagnostic performance, highlighting the need for platform-specific calibration before clinical use
